| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AKARI THERAPEUTICS PLC | 46,622 | 516,000 | 0.10% | ||
| 2 | XENON PHARMACEUTICALS INC | 150,000 | 600,000 | 0.11% | ||
| 3 | FOAMIX PHARMACEUTICALS LTD | 125,000 | 619,000 | 0.12% | ||
| 4 | AVEO PHARMACEUTICALS INC | 1,500,000 | 885,000 | 0.16% | ||
| 5 | MIRATI THERAPEUTICS INC COM | 172,184 | 895,000 | 0.17% | ||
| 6 | ZOSANO PHARMA CORP | 940,000 | 1,786,000 | 0.33% | ||
| 7 | CURRENCYSHARES SWISS FRANC T | 19,300 | 1,835,000 | 0.34% | ||
| 8 | STEMLINE THERAPEUTICS INC | 225,000 | 1,924,000 | 0.36% | ||
| 9 | PTC THERAPEUTICS INC | 200,000 | 1,968,000 | 0.37% | ||
| 10 | CONFORMIS INCORPORATED | 400,000 | 2,088,000 | 0.39% | ||
| 11 | CYMABAY THERAPEUTICS INC | 500,000 | 2,150,000 | 0.40% | ||
| 12 | DERMIRA INC COM | 65,000 | 2,217,000 | 0.41% | ||
| 13 | INTRA-CELLULAR THERAPIES INC | 150,000 | 2,438,000 | 0.45% | ||
| 14 | IRIDEX CORP | 250,000 | 2,968,000 | 0.55% | ||
| 15 | RIGEL PHARMACEUTICAL INC | 1,100,000 | 3,641,000 | 0.68% | ||
| 16 | AQUINOX PHARMACEUTICALS INC | 225,000 | 3,755,000 | 0.70% | ||
| 17 | COLLEGIUM PHARMACEUTICAL INC COM | 375,000 | 3,773,000 | 0.70% | ||
| 18 | ZOGENIX INC | 365,000 | 3,960,000 | 0.74% | ||
| 19 | BLUEPRINT MEDICINES CORP COM | 100,000 | 3,999,000 | 0.75% | ||
| 20 | SPECTRANETICS CORP | 155,000 | 4,514,000 | 0.84% | ||
| 21 | INCYTE CORP | 35,000 | 4,678,000 | 0.87% | ||
| 22 | ENTELLUS MED INC | 375,000 | 5,175,000 | 0.96% | ||
| 23 | SHIRE PLC | 30,000 | 5,227,000 | 0.97% | ||
| 24 | NXSTAGE MED INC COM | 200,000 | 5,366,000 | 1.00% | ||
| 25 | PROTHENA CORP PLC | 100,000 | 5,579,000 | 1.04% | ||
| 26 | Wright Medical Group NV | 185,000 | 5,757,000 | 1.07% | ||
| 27 | K2M GROUP HLDGS INC COM | 285,000 | 5,845,000 | 1.09% | ||
| 28 | ACORDA THERAPEUTICS INC | 300,000 | 6,300,000 | 1.17% | ||
| 29 | RA PHARMACEUTICALS INC COM | 300,000 | 6,387,000 | 1.19% | ||
| 30 | NOVADAQ TECHNOLOGIES INC | 900,000 | 7,011,000 | 1.31% | ||
| 31 | SAGE THERAPEUTICS INC | 100,000 | 7,107,000 | 1.32% | ||
| 32 | ACADIA PHARMACEUTICALS INC COM | 207,200 | 7,124,000 | 1.33% | Put | |
| 33 | AGIOS PHARMACEUTICALS INC | 125,000 | 7,300,000 | 1.36% | ||
| 34 | TESARO INCORPORATED | 50,000 | 7,694,000 | 1.43% | Call | |
| 35 | PORTOLA PHARMACEUTICALS INC | 200,000 | 7,838,000 | 1.46% | ||
| 36 | NANOSTRING TECHNOLOGIES INC | 400,000 | 7,948,000 | 1.48% | ||
| 37 | BRISTOL MYERS SQUIBB CO | 150,000 | 8,157,000 | 1.52% | Call | |
| 38 | GENMARK DIAGNOSTICS INC. | 650,000 | 8,333,000 | 1.55% | ||
| 39 | PUMA BIOTECHNOLOGY | 225,000 | 8,370,000 | 1.56% | ||
| 40 | ADURO BIOTECH INC | 800,000 | 8,600,000 | 1.60% | ||
| 41 | LION BIOTECHNOLOGIES INC COM | 1,200,000 | 8,940,000 | 1.67% | ||
| 42 | NUVASIVE INC | 120,000 | 8,962,000 | 1.67% | ||
| 43 | ENANTA PHARMACEUTICALS INC | 300,000 | 9,240,000 | 1.72% | ||
| 44 | ENDOLOGIX INC | 1,300,000 | 9,412,000 | 1.75% | ||
| 45 | SPECTRANETICS CORP | 325,000 | 9,464,000 | 1.76% | Call | |
| 46 | MERCK & CO INC | 150,000 | 9,531,000 | 1.78% | ||
| 47 | IMMUNOMEDICS INCORPORATED | 1,500,000 | 9,705,000 | 1.81% | ||
| 48 | VERTEX PHARMACEUTICALS INC | 90,000 | 9,842,000 | 1.83% | ||
| 49 | AERIE PHARMACEUTICALS INC COM | 220,000 | 9,977,000 | 1.86% | Call | |
| 50 | EPIZYME INC COM | 600,000 | 10,290,000 | 1.92% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-17-002733, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
